Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.
Zeena Nackerdien, PhD
Advertisement
Zeena Nackerdien is a scientist and medical writer who previously performed research at institutions such as the National Institutes of Standards and Technology, Memorial Sloan Kettering Cancer, and Rockefeller University. Zeena has contributed this work independently of her current writing assistance to researchers at Montefiore Medical Center and has no conflicts of interest to declare.
Articles by Zeena Nackerdien, PhD
Hospital-acquired pneumonia (HAP), including ventilator-associated (VAP) and non-ventilator (NVHAP) forms, poses significant health risks, contributing to mortality, readmission, and high costs.
Read this informative article on mitigating central line-associated bloodstream infections (CLABSIs) in acute care settings, which is crucial for enhancing patient safety.
Advertisement
Latest Updated Articles
CLABSI Prevention in the Post-COVID-19 EraPublished: August 29th 2024 | Updated:
Advertisement
Advertisement
Trending on Infection Control Today
1
Copper-Embedded Textiles Show Promise in Reducing Microbial Burden and Supporting Infection Control
2
Investing in Anti-HIV: How Anti-HIV Therapeutic Developers Can Reshape the Future of HIV Control
3
Why is Precleaning a Critical Role in Medical and Dental Instrument Care?
4
